Clinical Trial Update: Effects of Granulocyte Colony-stimulating Factor (G-CSF), Trastuzumab, and Vinorelbine on Immune Cell Function [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluated the effects of combining granulocyte colony-stimulating factor (G-CSF), trastuzumab, and vinorelbine on immune cell function in meta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Filgrastim (G-CSF) (filgrastim)
• Trastuzumab (trastuzumab)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Metastatic Breast Cancer | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2018-07-20